It is important to note that ‘enrichment’ does not mean ‘increase’ or ‘upregulation.’ The enrichment in insulin signaling, for example, highlights the involvement of this pathway in the epilepsy phenotype and selenate treatment, but unfortunately provides no information about the direction of change (upregulation or downregulation). This evidence concerns the gene INS and epilepsy.